<DOC>
	<DOCNO>NCT01641029</DOCNO>
	<brief_summary>Pyelonephritis serious infection manifest fever , back pain , nausea , vomit . In U.S. , estimate 20 case pyelonephritis per 10,000 annually , high incidence young woman . Escherichia coli ( E. coli ) cause 80 % infection . Over last two decade , E. coli resistance emerge commonly prescribe antimicrobial , ampicillin trimethoprim-sulfamethoxazole ( TMP/SMX ) . Most recently , resistance fluoroquinolones strain produce extended-spectrum beta-lactamase ( ESBL ) observe . In order well understand evolution current state antibiotic resistance among E. coli urinary tract isolate well inform treatment decision , investigator propose conduct investigation : ) determine prevalence antimicrobial resistance among E. coli cause acute pyelonephritis various patient group , specifically healthy community-dwellers uncomplicated infection , b ) determine specific prevalence fluoroquinolone-resistance ESBL-producing E. coli , c ) determine potential risk factor fluoroquinolone ESBL-producing E. coli infection .</brief_summary>
	<brief_title>Community-Associated Uropathogen Antimicrobial Resistance Among Emergency Department Patients With Acute Pyelonephritis</brief_title>
	<detailed_description />
	<mesh_term>Emergencies</mesh_term>
	<mesh_term>Pyelonephritis</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>patient &gt; 18 year age flank pain and/or costovertebral angle tenderness document temperature emergency department ≥38°C/100.4°F method measurement , documented temperature emergency department ≥38°C/100.4°F method measurement , complicate pyelonephritis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>